Lifevantage Price to Book Ratio 2012-2026 | LFVN
Historical price to book ratio values for Lifevantage (LFVN) over the last 10 years. The current price to book ratio for Lifevantage as of September 16, 2026 is 2.32.
| Lifevantage Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 6.18 | 2.30 | |
| 2026-06-30 | 6.19 | $2.68 | 2.31 |
| 2026-03-31 | 4.26 | $2.64 | 1.61 |
| 2025-12-31 | 6.01 | $2.58 | 2.33 |
| 2025-09-30 | 9.44 | $2.61 | 3.61 |
| 2025-06-30 | 12.64 | $2.79 | 4.53 |
| 2025-03-31 | 14.04 | $2.70 | 5.19 |
| 2024-12-31 | 16.84 | $2.38 | 7.07 |
| 2024-09-30 | 11.57 | $2.22 | 5.22 |
| 2024-06-30 | 6.12 | $2.08 | 2.95 |
| 2024-03-31 | 5.74 | $2.11 | 2.72 |
| 2023-12-31 | 5.67 | $2.12 | 2.67 |
| 2023-09-30 | 6.06 | $2.31 | 2.63 |
| 2023-06-30 | 3.85 | $2.75 | 1.40 |
| 2023-03-31 | 3.15 | $2.62 | 1.20 |
| 2022-12-31 | 3.24 | $2.51 | 1.29 |
| 2022-09-30 | 3.24 | $2.54 | 1.28 |
| 2022-06-30 | 3.73 | $2.52 | 1.48 |
| 2022-03-31 | 4.05 | $2.71 | 1.50 |
| 2021-12-31 | 5.38 | $2.71 | 1.99 |
| 2021-09-30 | 5.76 | $2.82 | 2.04 |
| 2021-06-30 | 6.26 | $2.70 | 2.31 |
| 2021-03-31 | 7.96 | $2.55 | 3.12 |
| 2020-12-31 | 7.93 | $2.51 | 3.16 |
| 2020-09-30 | 10.27 | $2.40 | 4.29 |
| 2020-06-30 | 11.51 | $2.32 | 4.95 |
| 2020-03-31 | 8.77 | $2.00 | 4.38 |
| 2019-12-31 | 13.29 | $2.04 | 6.53 |
| 2019-09-30 | 11.66 | $2.11 | 5.52 |
| 2019-06-30 | 11.05 | $1.93 | 5.73 |
| 2019-03-31 | 12.16 | $1.73 | 7.04 |
| 2018-12-31 | 11.23 | $1.47 | 7.62 |
| 2018-09-30 | 9.35 | $1.67 | 5.61 |
| 2018-06-30 | 5.42 | $1.56 | 3.48 |
| 2018-03-31 | 3.07 | $1.35 | 2.28 |
| 2017-12-31 | 4.05 | $1.16 | 3.49 |
| 2017-09-30 | 3.59 | $1.11 | 3.24 |
| 2017-06-30 | 3.69 | $1.02 | 3.61 |
| 2017-03-31 | 4.57 | $0.98 | 4.68 |
| 2016-12-31 | 6.94 | $1.03 | 6.72 |
| 2016-09-30 | 8.05 | $1.00 | 8.04 |
| 2016-06-30 | 11.58 | $0.76 | 15.25 |
| 2016-03-31 | 7.75 | $0.63 | 12.28 |
| 2015-12-31 | 8.10 | $0.50 | 16.18 |
| 2015-09-30 | 4.83 | $0.33 | 14.74 |
| 2015-06-30 | 3.16 | $0.24 | 13.26 |
| 2015-03-31 | 4.71 | $0.20 | 23.05 |
| 2014-12-31 | 7.75 | $0.32 | 24.06 |
| 2014-09-30 | 6.79 | $0.50 | 13.60 |
| 2014-06-30 | 8.58 | $0.27 | 31.39 |
| 2014-03-31 | 7.81 | $0.18 | 42.54 |
| 2013-12-31 | 9.83 | $-0.04 | -266.43 |
| 2013-09-30 | 14.18 | $2.09 | 6.80 |
| 2013-06-30 | 13.82 | $2.03 | 6.81 |
| 2013-03-31 | 14.00 | $2.15 | 6.51 |
| 2012-12-31 | 13.05 | $2.16 | 6.05 |
| 2012-09-30 | 20.44 | $2.12 | 9.66 |
| 2012-06-30 | 16.86 | $1.80 | 9.39 |
| 2012-03-31 | 22.40 | $1.44 | 15.52 |
| 2011-12-31 | 8.52 | $0.65 | 13.03 |
| 2011-09-30 | 8.94 | $-1.14 | -7.82 |
| 2011-06-30 | 8.94 | $-1.47 | -6.06 |
| 2011-03-31 | 4.23 | 0.00 | |
| 2010-12-31 | 2.32 | 0.00 | |
| 2010-09-30 | 2.98 | 0.00 | |
| 2010-06-30 | 3.04 | 0.00 | |
| 2010-03-31 | 2.32 | 0.00 | |
| 2009-12-31 | 1.49 | 0.00 | |
| 2009-09-30 | 2.29 | 0.00 | |
| 2009-06-30 | 3.99 | 0.00 | |
| 2009-03-31 | 4.62 | 0.00 | |
| 2008-12-31 | 1.19 | 0.00 | |
| 2008-09-30 | 1.19 | 0.00 | |
| 2008-06-30 | 1.49 | 0.00 | |
| 2008-03-31 | 1.40 | 0.00 | |
| 2007-12-31 | 1.19 | 0.00 | |
| 2007-09-30 | 1.31 | 0.00 | |
| 2007-06-30 | 1.43 | 0.00 | |
| 2007-03-31 | 2.03 | 0.00 | |
| 2006-12-31 | 2.62 | 0.00 | |
| 2006-09-30 | 4.41 | 0.00 | |
| 2006-06-30 | 5.06 | 0.00 | |
| 2006-03-31 | 13.41 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.077B | $0.183B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |